StockNow
Sign up
U.S. Markets

Moderna (MRNA) Q2 2026 (USD): EPS -1.97 (exp. -2.03), Revenue 145mln (exp. 102.9mln)

StockNow breaking-news AI analysis

Moderna beat Q2 revenue and EPS expectations, reporting a 145 million USD revenue and -1.97 USD EPS, though the company remains in a net loss position amidst mixed market sentiment.

News detail

Net income -800mln (exp. -813mln).

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Geopolitics

US President Trump says the Iran war is going well; US is hitting Iran hard and "we just keep winning", according to Fox News

Politics

US Treasury has reportedly informed banks that it may intervene in the Yen market on Friday, according to sources

Fed

Fed's Kashkari (2026 voter, hawkish dissenter) says he dissented because he preferred to raise funds rate by 0.25%

See more of today’s market highlights in StockNow.See more →